Literature DB >> 24913808

Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors.

Ahmet Alacacioglu1, Eda Ulger, Umut Varol, Tugba Yavuzsen, Murat Akyol, Yasar Yildiz, Ibrahim Yildiz, Vedat Bayoglu, Ahmet Dirican, Lutfiye Demir, Tarik Salman, Yuksel Kucukzeybek, Inci Alacacioglu, Huseyin Can, Mustafa Oktay Tarhan.   

Abstract

We aimed to investigate anxiety, depression and sexual satisfaction levels of testicular cancer survivors (TCSs) and compare the scores with healthy men's. The Hospital Anxiety and Depression Scale (HADS), Golombok-Rust Inventory of Sexual Satisfaction (GRISS) and European Organization for Research on Treatment of Cancer Questionnaires Quality of Life-C30 were used. Forty-one TCSs and thirty-eight healthy men were participated in this study. The total HADs scores of TCSs (12.21 ± 8.19) were less than the healthy group (14.44 ± 6.53; p > 0.05). The high depression scores rate was 29.2 and 55.2, and high anxiety scores rate was 24.4 and 28.9 for TCSs and healthy group, respectively. When we evaluated GRISS subscores and anxiety levels, we found significantly increase only in avoidance subscores in the TCSs (p = 0.04). When we evaluated GRISS subscores and depression levels, GRISS subscores of the TCSs who had high depression scores were also high. However, statistical significance was found in satisfaction (p = 0.009), touch (p = 0.04), avoidance (p = 0.01) and erectile dysfunction (p = 0.04) subscores in the TCSs. In the TCSs whose anxiety scores were high, emotional functioning (p = 0.009) and global QoL (p = 0.01) subscores of GRISS was found significantly low. In the TCSs whose depression scores were high, physical (p = 0.01), cognitive (p = 0.04), emotional (p = 0.03), social functioning (p = 0.02) and global QoL (p < 0.001) subscores of GRISS were found significantly low. Anxiety, depression and sexual satisfaction levels of TCSs were found to be similar with the control population.

Entities:  

Mesh:

Year:  2014        PMID: 24913808     DOI: 10.1007/s12032-014-0043-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  Psychosocial well-being in testicular cancer patients.

Authors:  S Kaasa; N Aass; A Mastekaasa; E Lund; S D Fosså
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

Review 2.  Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.

Authors:  J P van Basten; H J Hoekstra; M F van Driel; H S Koops; J H Droste; G Jonker-Pool; H B van de Wiel; D T Sleijfer
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Study of anxiety disorder and depression in long-term survivors of testicular cancer.

Authors:  Alv A Dahl; Carl Fredrik Haaland; Arnstein Mykletun; Roy Bremnes; Olav Dahl; Olbjørn Klepp; Erik Wist; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

Review 4.  Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review.

Authors:  M D Shelley; K Burgon; M D Mason
Journal:  Cancer Treat Rev       Date:  2002-10       Impact factor: 12.111

Review 5.  Quality of life in survivors of testicular cancer.

Authors:  Alv A Dahl; Arnstein Mykletun; Sophie D Fosså
Journal:  Urol Oncol       Date:  2005 May-Jun       Impact factor: 3.498

Review 6.  Quality-of-life issues in the treatment of testicular cancer.

Authors:  A Heidenreich; R Hofmann
Journal:  World J Urol       Date:  1999-08       Impact factor: 4.226

7.  Adaptive behavioral responses to potential infertility among survivors of testis cancer.

Authors:  P P Rieker; E M Fitzgerald; L A Kalish
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Testicular cancer: the psychosocial problems of patients and their relatives.

Authors:  C Moynihan
Journal:  Cancer Surv       Date:  1987

Review 10.  Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer.

Authors:  Sophie D Fosså
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

View more
  4 in total

Review 1.  Testicular cancer survivorship: Long-term toxicity and management.

Authors:  Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

2.  Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature.

Authors:  Jennifer A Soon; Angelyn Anton; Javier Torres; Ruth Lawrence; Phillip Parente; Joseph McKendrick; Ian D Davis; Carmel Pezaro
Journal:  Support Care Cancer       Date:  2018-10-22       Impact factor: 3.603

3.  Quality of life in penile carcinoma patients - post-total penectomy.

Authors:  Roman Sosnowski; Marta Kulpa; Mariola Kosowicz; Jan Karol Wolski; Olga Kuczkiewicz; Katarzyna Moskal; Michał Szymański; Tomasz Kalinowski; Tomasz Demkow
Journal:  Cent European J Urol       Date:  2016-06-20

4.  "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".

Authors:  François Gernier; Djihane Ahmed-Lecheheb; Patricia Pautier; Anne Floquet; Cédric Nadeau; Sophie Frank; Jérôme Alexandre; Frédéric Selle; Dominique Berton-Rigaud; Elsa Kalbacher; Hubert Orfeuvre; Alain Lortholary; Paule Augereau; Fabien Labombarda; Lionel Perrier; Jean-Michel Grellard; Idlir Licaj; Bénédicte Clarisse; Aude-Marie Savoye; Héloise Bourien; Thibaut De La Motte Rouge; Jean-Emmanuel Kurtz; Katia Kerdja; Anaïs Lelaidier; Amandine Charreton; Isabelle Ray-Coquard; Florence Joly
Journal:  BMC Cancer       Date:  2021-10-26       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.